No Data
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team With Appointment of Gary Ainsworth as Vice President of Market Access
Express News | Tonix Pharmaceuticals Holding Corp - Expects Topline Data for Tnx-1300 in Q3 2025, Tnx-1500 in Q1 2025
Tonix Pharmaceuticals Achieves Key Milestone With FDA Review Timeline for Innovative Fibromyalgia Treatment | NASDAQ:TNXP
Trending Stocks Today | Nocera Surges 63.95% Post-Market
Tonix Pharmaceuticals Announces PDUFA Goal Date Of August 15, 2025, For FDA Decision On U.S. Marketing Approval For TNX-102 SL For Fibromyalgia
Express News | Tonix Pharmaceuticals Announces Pdufa Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for Tnx-102 Sl for Fibromyalgia
No Data
ns5 : i will average at 18 cents
lostmypizza ns5 : sounds like a good number
ken jc : wait
try to load around 0.2/0.22
ken jc : the lowest the better
somebody are dumping for days
ken jc : or you could buy small amount first
View more comments...